Research Money Inc.

Toronto Innovation Acceleration Partners joins with biotech giant Amgen to fund disruptive technologies

Mark Mann
September 11, 2019

The commercialization organization formerly known as MaRS Innovation announced a new collaboration with the biotechnology company Amgen, to identify and jointly fund disruptive technologies derived from discovery research conducted in Toronto.

... Please become a Member or to read the rest of this article ...

Other stories mentioning these organizations, people and topics

Organizations:	AMGen, Amgen Canada, Evotec, LAB150, Toronto Innovation Partners (TIAP), and University Hospital Network
People:	Francesco Di Marco, Philip Tagari, and Rafi Hofstein
Topics:	Commercialization, disruptive technologies, drug discovery, and pharmaceutical sector

Toronto Innovation Acceleration Partners joins with biotech giant Amgen to fund disruptive technologies

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

Toronto Innovation Acceleration Partners joins with biotech giant Amgen to fund disruptive technologies

Events For Leaders in Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

Events For Leaders in
Science, Tech, Innovation, and Policy